Bone Remodeling Markers in Assessing of Sternal Reparative Regeneration in Patients With Carbohydrate Metabolism Disorders After Coronary Bypass Surgery

Aim      To study time-related changes in bone remodeling markers in patients with ischemic heart disease (IHD) associated with type 2 diabetes mellitus (DM) and disorders of carbohydrate metabolism (CM). Also, a possibility was studied of using these markers for evaluation of breast bone reparative regeneration in early and late postoperative periods following coronary bypass (CB).

Materials and methods           This study included 28 patients with IHD and functional class II-III exertional angina after CB. Patients were divided into 2 groups based on the presence (group 1) and absence (group 2) of CM disorders. Contents of osteocalcin (OC), C-terminal telopeptide (CTTP) of type 1 collagen, deoxypyridinoline (DPD), and alkaline phosphatase bone isoenzyme (ALPBI) were measured by enzyme immunoassay on admission (Т1) and at early (Т2) and late (Т3) postoperative stages. Sternal scintigraphy with a radiopharmaceutical (RP) was performed at stage 3 following sternotomy.

Results The content of OC and CTTP was reduced in group 1 compared to the values in the group without CM disorders (р<0.005) at stages Т1 and Т2. There were no significant intergroup differences in concentrations of ALPBI and DPD throughout the study. Time-related changes in OC, CTTP, and DPD had some intergroup differences: the increase in biomarkers was observed in group 1 considerably later, at stage Т3 (р<0.005), while in group 2, it was observed at stage T2 after sternotomy. Scintigraphy revealed significant intergroup differences in the intensity of RP accumulation in sternal tissue.

Conclusion      The intergroup differences in the content of biomarkers evidenced a disbalance among processes of formation and resorption of bone tissue and delayed remodeling processes in patients with IHD associated with type 2 DM and CM disorders. The study confirmed significance of comprehensive evaluation of time-related changes in markers for bone tissue metabolism and sternal scintigraphy for diagnosis and evaluation of sternal reparative regeneration following sternotomy in patients with IHD associated with type 2 DM and disorders of CM metabolism.

1. Neumann F-J, Sousa-Uva M, Ahlsson A, Alfonso F, Banning AP, Benedetto U et al. 2018 ESC/EACTS guidelines on myocardial revascularization. Russian Journal of Cardiology. 2019;24(8):151-226. https://doi.org/10.15829/1560-4071-2019-8-151-226

2. Bokeria L.A., Aronov D.M. Russian clinical guidelines Coronary artery bypass grafting in patients with ischemic heart disease: rehabilitation and secondary prevention. CardioSomatics. 2016;7(3-4):5-71.

3. Bezdenezhnykh N.A., Sumin A.N., Barbarash O.L. Diabetes patient and myocardial revascularization from the evidence guided perspective: cardiologist opinion. Part 2. Russian Journal of Cardiology. 2017;22(5):146- 52. https://doi.org/10.15829/1560-40712017-5-146-152

4. Dedov I.I., Shestakova M.V., Mayorov A.Yu., Vikulova O.K., Galstyan G.R., Kuraeva T.L. et al. Standards of specialized diabetes care. Edited by Dedov II, Shestakova MV, Mayorov AY. 8th edition. Diabetes mellitus. 2017;20(1S):1-121. https://doi.org/10.14341/DM20171S8

5. Serebryakova V.N., Trubacheva I.A., Kaveshnikov V.S., Khamedova M.Sh., Gusakova A.M., Suslova T.E. Abnormalities of lipid and carbohydrate metabolism in population of female intellectual workers. Siberian Medical Journal (Tomsk). 2014;29(2):79-84.

6. Sanches CP, Vianna AGD, Barreto F de C. The impact of type 2 diabetes on bone metabolism. Diabetology & Metabolic Syndrome. 2017;9(1):85. https://doi.org/10.1186/s13098-017-0278-1

7. Hygum K, Starup-Linde J, Harsløf T, Vestergaard P, Langdahl BL. Mechanisms in endocrinology: Diabetes mellitus, a state of low bone turnover - a systematic review and meta-analysis. European Journal of Endocrinology. 2017;176(3):R137-57. https://doi.org/10.1530/EJE-16-0652

8. Olbrecht VA, Barreiro CJ, Bonde PN, Williams JA, Baumgartner WA, Gott VL et al. Clinical Outcomes of Noninfectious Sternal Dehiscence After Median Sternotomy. The Annals of Thoracic Surgery. 2006;82(3):902- 7. https://doi.org/10.1016/j.athoracsur.2006.04.058

9. Shih C-C, Shih C-M, Su Y-Y, Lin S-J. Potential risk of sternal wires. European Journal of Cardio-Thoracic Surgery. 2004;25(5):812-8. https://doi.org/10.1016/j.ejcts.2003.11.043

10. Gatti G, Dell’Angela L, Maschietto L, Luzzati R, Sinagra G, Pappalardo A. The Impact of Diabetes on Early Outcomes after Routine Bilateral Internal Thoracic Artery Grafting. Heart, Lung and Circulation. 2016;25(8):862- 9. https://doi.org/10.1016/j.hlc.2016.02.009

11. Zioupos P, Currey JD. Changes in the Stiffness, Strength, and Toughness of Human Cortical Bone With Age. Bone. 1998;22(1):57-66. https://doi.org/10.1016/S8756-3282(97)00228-7

12. Greenblatt MB, Tsai JN, Wein MN. Bone Turnover Markers in the Diagnosis and Monitoring of Metabolic Bone Disease. Clinical Chemistry. 2017;63(2):464-74. https://doi.org/10.1373/clinchem.2016.259085

13. Starup-Linde J, Vestergaard P. Biochemical bone turnover markers in diabetes mellitus - A systematic review. Bone. 2016;82:69-78. https://doi.org/10.1016/j.bone.2015.02.019

14. Grebennikova T.A., Troshina V.V., Belaia Zh.E. Markers and genetic predictors of osteoporosis in routine clinical practice. Consilium Medicum. 2019;21(4):97-102. https://doi.org/10.26442/20751753.2019.4.190323

15. Mikosch P. Bone scintigraphy for the diagnosis of metabolic bone diseases. Wiener Medizinische Wochenschrift. 2004;154(5-6):119-26. https://doi.org/10.1007/s10354-004-0053-4

16. Kozlov B.N., Nasrashvili G.G., Kuznetsov M.S., Panfilov D.S, Gusakova A.M., Saushkin V.V. et al. Paraclinical methods of research of sternal bone consolidation after cold plasma and standard sternotomy. Modern Problems of Science and Education. 2015;3:99.